Q-BRM Trademark

Trademark Overview

On Tuesday, May 12, 2026, a trademark application was filed for Q-BRM with the United States Patent and Trademark Office. The USPTO has given the Q-BRM trademark a serial number of 99818402. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 12, 2026. This trademark is owned by GNQ Insilico Inc.. The Q-BRM trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:

Licensing of software

Software as a service (SAAS) services featuring software for causal pathway analysis, genomic variant scoring, drug simulation, and biomarker trajectory modeling in the fields of drug discovery and pharmaceutical research, using artificial intelligence (AI) and machine learning technology; Platform as a service (PAAS) featuring computer software platforms for causal pathway analysis, genomic variant scoring, drug simulation, and biomarker trajectory modeling in the fields of drug discovery and pharmaceutical research, using artificial intelligence (AI) and machine learning technology
q-brm

General Information

Serial Number99818402
Word MarkQ-BRM
Filing DateTuesday, May 12, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, May 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesLicensing of software
Pseudo MarkQ BRM
Goods and ServicesSoftware as a service (SAAS) services featuring software for causal pathway analysis, genomic variant scoring, drug simulation, and biomarker trajectory modeling in the fields of drug discovery and pharmaceutical research, using artificial intelligence (AI) and machine learning technology; Platform as a service (PAAS) featuring computer software platforms for causal pathway analysis, genomic variant scoring, drug simulation, and biomarker trajectory modeling in the fields of drug discovery and pharmaceutical research, using artificial intelligence (AI) and machine learning technology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2026
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGNQ Insilico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPLEASANTON, CA 94588
US

Trademark Events

Event DateEvent Description
Tuesday, May 12, 2026NEW APPLICATION ENTERED
Tuesday, May 12, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

software drug pharmaceutical discovery fields research modeling artificial learning technology